A practical clinical safety manual for professionals supporting patients receiving bispecific antibody therapy. Bispecific Antibody Therapy Clinical Safety Manual provides a structured, practice-focused approach to the safety challenges surrounding modern T-cell-engaging therapies. Written for oncology and hematology nurses, advanced practice clinicians, pharmacists, prescribers, infusion teams, inpatient clinicians, emergency teams, and clinical educators, this manual follows the patient from treatment readiness through administration, acute surveillance, escalation, discharge, and longitudinal follow-up. Rather than focusing on one product or dosing schedule, the book emphasizes durable safety principles that can be integrated with current prescribing information and institutional protocols. Readers are guided through treatment-phase verification, baseline assessment, step-up dosing, premedication, monitoring, cytokine release syndrome recognition, neurotoxicity and ICANS surveillance, infection prevention, cytopenia management, tumor lysis risk, organ dysfunction, emergency transfer, caregiver education, and quality improvement. Inside this manual, readers will find: Patient-selection and treatment-readiness frameworks Step-up dosing, administration, and observation safety principles CRS recognition, grading, reassessment, and escalation pathways Structured ICANS and neurologic surveillance using baseline comparison and ICE assessment principles Infection, neutropenia, hypogammaglobulinemia, and immune-deficiency monitoring Guidance for cytopenias, bleeding, tumor lysis physiology, renal and hepatic dysfunction, and cardiopulmonary complications Rapid-response, emergency-transfer, and critical-care readiness tools Discharge teach-back, caregiver education, telephone triage, and longitudinal follow-up systems Clinical checklists, surveillance worksheets, handoff tools, quick-reference aids, and applied decision drills Program-quality, staff-competency, simulation, auditing, and continuous-improvement strategies The manual is designed to help clinical teams recognize meaningful change early, communicate clearly, support physiology, maintain a broad differential diagnosis, and escalate care before preventable deterioration occurs. Ideal for: oncology and hematology nursing teams, infusion centers, cellular and immune therapy programs, advanced practice professionals, hospital educators, emergency and critical-care clinicians, pharmacists, and healthcare organizations developing or strengthening bispecific antibody safety pathways.
